Lumos Pharma, Inc. (LUMO) News Headlines

▮ More

Date

Headline

7/28/2020 3:06:03 AM MRNA, PFE/BNTX COVID-19 Vaccines Move Into Phase 3, CytoDyn On Watch, GNCA To Report Data On Jul.30

2/28/2020 9:15:54 AM NewLink Genetics Q4 Net Loss $8.3 Mln Or $0.22 Per Share

10/1/2019 9:18:32 PM Today's Top 5 Losers In Healthcare Sector (NERV, NLNK, CYCN…)

4/2/2019 8:18:23 AM NewLink Genetics Presents Encouraging Phase 2 Results For NLG207 In Ovarian Cancer At AACR 2019

11/15/2018 9:13:52 AM NewLink Genetics Says Merck Begins Rolling Submission Of Licensure Application For Ebola Vaccine V920 To FDA

8/1/2018 11:14:28 PM XENT Trims Revenue Outlook, CTXR On Watch, Busy Year Ahead For NLNK

7/3/2018 1:44:33 AM FDA Nod For ALKS, TRXC Sees 4-fold Increase In Q2 Revenue, BCLI On Watch

7/2/2018 8:08:11 AM NewLink Genetics Presents Positive Updated Phase 1 Data With Indoximod Plus Radio-Immunotherapy

6/30/2018 2:04:54 AM An Ear To The Pharma: 6 Stocks To Watch (ALKS, ZGNX, ACOR...)

4/16/2018 12:47:02 AM ALNY On Watch, NLNK Exhibits Caution, Keep An Eye On GKOS

4/15/2018 5:01:05 PM NewLink Genetics Announces Initial Phase 1 Data With Indoximod Plus Radiation And Chemotherapy

4/9/2018 7:20:03 AM NewLink Genetics (NLNK) Tumbled To A New Low For The Year

4/7/2018 11:02:20 PM An Ear To The Pharma: 9 Stocks To Watch This Week (SELB, AGLE, BPMC, MNOV…)

4/6/2018 3:03:01 PM NewLink Genetics Announces Review Of Clinical Programs

4/6/2018 9:49:12 AM NewLink Genetics (NLNK) Has Dropped To A New Low For The Year

1/8/2018 8:25:35 AM NewLink Genetics Updates Clinical And Financial Guidance

11/2/2017 8:19:16 AM NewLink Genetics Q3 Net Loss $20.6 Mln Or $0.69/Shr Vs Loss Of $15.5 Mln Or $0.54/Shr Last Year

10/30/2017 9:06:03 AM NewLink Genetics Says Indoximod Granted Orphan-drug Designation By FDA

10/4/2017 2:11:01 AM CLSN Is Hot & Newsy, CTMX Soars On AMGN Deal, SUNFISH Fails To Help PTCT Shine

10/3/2017 9:09:05 PM NewLink Genetics Announces Pricing Of Underwritten Public Offering Of 5 Mln Shares At $10.25/shr

Latest Headlines